Abstract:Abstract2-n-propylquinoline (2-PQ) is a natural compound having interesting anti-leishmanial activities by the oral route but with a rapid elimination rate. 2-PQ is insoluble in water and therefore cannot be administered intravenously. In this study, water-soluble polymeric prodrugs of 2-PQ were synthesized for intravenous administration with the objective of treating patients having severe visceral leishmaniasis with recurrent vomiting. As 2-PQ has no functional groups for tethering onto a soluble polymer, two amine derivatives of 2-PQ, (E)-2-(3-(2-ammonioethoxy)-3-oxoprop-1-en-1-yl)quinolin-1-ium chloride (1) and (E)-2-(3-(2-ammonioethyl)amino)-3-oxoprop-1-en-1-yl)quinolin-1-ium chloride (2), were synthesized and characterized using 1H and 13C NMR, IR, and mass spectroscopy. Both compounds (1) and (2) were soluble in water. They were tethered onto oxidized polyglucose (PG) at ~ 20 wt% concentration via imine linkages susceptible to hydrolysis. In vitro release at 37 °C into phosphate buffer showed that around 75% of both the compounds was released in 24 h. The parent compounds and their conjugates were evaluated for their anti-leishmanial activity both in vitro, and in vivo in a Leishmania donovani/Balb/c mice model. In vitro, the most active compound was (1) with an IC50 value of 5.67 ± 0.0.44 μg/mL against axenic and 8.34 ± 0.74 μg/mL against intramacrophage amastigotes. In vivo, both compounds (1) and (2) were less active at a dose of 10 mg/kg body weight showing a reduction in parasite burden of 30.2 and 21.7% respectively. The conjugates of (1) and (2) with PG were inactive in vivo. Probably, much higher concentrations of the conjugates and prolonged treatment times are necessary for potential anti-leishmanial activity.Lay Summary2-n-propylquinoline (2-PQ) is a natural compound having anti-leishmanial activities by the oral route but with a rapid elimination rate. 2-PQ is insoluble in water and therefore cannot be administered intravenously. As 2-PQ has no functional groups, two amine derivatives of 2-PQ were synthesized and conjugated to oxidized polyglucose. The parent compounds and their conjugates were evaluated for their anti-leishmanial activity both in vitro, and in vivo in a Leishmania donovani/Balb/c mice model. The new compounds were less active compared to AmBisome® both in vitro and in vivo and the conjugates were not active. Possibly, multiple injections and prolonged treatment durations are necessary for better in vivo response.

Synthesis of Deuterated Endochin‐Like Quinolones

Novel Synthesis Of Arylfluoroquinolone Antimicrobial Agents

Engineered Monoamine Oxidase-Catalyzed Deracemization of Sterically Hindered Acylaminomethyl-tetrahydroisoquinoline: Asymmetric Synthesis of (R)-(−)-praziquantel and Its Analogues

Antimalarial activity and mechanisms of action of two novel 4-aminoquinolines against chloroquine-resistant parasites

Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents

Regioselective Synthesis of Potential Non-Quinonoid Prodrugs of Plasmodione: Antiparasitic Properties Against Two Hemoglobin-Feeding Parasites and Drug Metabolism Studies

Synthesis of quinine‐inspired antimalarials by Ni‐catalysed cross electrophile coupling

A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection

A Divergent Synthesis of Numerous Pyrroloiminoquinone Alkaloids Identifies Promising Antiprotozoal Agents

Ultrasound-assisted synthesis and structure elucidation of novel quinoline-pyrazolo[1,5-a]pyrimidine hybrids for anti-malarial potential against drug-sensitive and drug-resistant malaria parasites and molecular docking

Designing novel anti-plasmodial quinoline–furanone hybrids: computational insights, synthesis, and biological evaluation targeting Plasmodium falciparum lactate dehydrogenase

Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4

C−H Activation Enables a Concise Total Synthesis of Quinine and Analogues with Enhanced Antimalarial Activity

New Water-Soluble Polymeric Prodrugs of 2-n-propylquinoline: Synthesis and Evaluation of In Vitro and In Vivo Activities Against Leishmania donovani

3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents

Synthesis of Novel 3-Subtituted-2-Thioxo-2,3-Dihydroquinazolin-4(1H)-One Derivatives Via the Cascade Reaction and Investigation of Their In Situ Antimicrobial Activity on Candida albicans

In silico Elucidation of Dihydroquinine Mechanism of Action against Toxoplasma gondii

Effective Microwave-Assisted Synthesis of 2-Chloro-5,6-dimethyl-3-(((substituted-benzylidene)hydrazono)methyl)-quinoline and Its Biological Assessment

Multicomponent Syntheses Enable the Discovery of Novel Quisinostat-Derived Chemotypes as Histone Deacetylase Inhibitors

Discovery of 1,3,4-oxadiazoles with slow-action activity against Plasmodium falciparum malaria parasites